Undisclosed atopic dermatitis therapeutic
/ Almirall, Evotec
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 24, 2024
Characterisation and Profiling of Standard Atopic Dermatitis Therapies in a Chronic Dermatitis Murine Model Induced by Oxazolone.
(PubMed, Exp Dermatol)
- "Atopic dermatitis (AD) is a common inflammatory skin disorder characterised by hypersensitivity to allergens, eczematous lesions and pruritus. Oral (cyclosporine, prednisolone and baricitinib) and topical treatments (betamethasone, tacrolimus and crisaborole) were effective inhibiting the induced pathology, as well as modulating the cytokine gene signature of AD. In conclusion, our 4 oxazolone challenges model recapitulates many of the key features of the disease and is responsive to AD standard of care therapies in humans."
Journal • Preclinical • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Inflammation • Pruritus • Psoriasis • IL13 • IL4
1 to 1
Of
1
Go to page
1